Your browser doesn't support javascript.
loading
Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States.
Mase, Sundari; Chorba, Terence; Parks, Samuel; Belanger, Ann; Dworkin, Felicia; Seaworth, Barbara; Warkentin, Jon; Barry, Pennan; Shah, Neha.
Affiliation
  • Mase S; World Health Organization, India Country Office, Delhi, India.
  • Chorba T; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Parks S; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Belanger A; Tuberculosis Control Branch, California Department of Public Health, Richmond, California, USA.
  • Dworkin F; Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, USA.
  • Seaworth B; Heartland National Tuberculosis Center, San Antonio, Texas, USA.
  • Warkentin J; Tuberculosis Elimination Program, Tennessee Department of Health, Nashville, Tennessee, USA.
  • Barry P; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Shah N; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Clin Infect Dis ; 71(4): 1010-1016, 2020 08 14.
Article in En | MEDLINE | ID: mdl-31556947
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Antitubercular Agents Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Antitubercular Agents Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2020 Type: Article